Anterion
Tomography, Optical Coherence. 510(k) K230897, from Heidelberg Engineering GmbH (Heidelberg, DE). Product code OBO, class 2.
As of Nov 19, 2026, K230897 is an FDA 510(k) held by Heidelberg Engineering GmbH, substantially equivalent on Oct 11, 2023 after 194 days, with no recalls tied to it in FDA's recall database.
- Review time: 194 days
- Recalls: 0
- Cited as a predicate by: 1 device
The ANTERION is a non-contact ophthalmic imaging and analysis device for the eye. It is intended for visualization and measurement of the anterior segment and measurement of the axial length. The analysis covers: • Cornea Thickness • Anterior Segment o Anterior chamber width, depth, volume and angle parameters o Lens Thickness • Axial Length
- AnterionK211817 · Heidelberg Engineering GmbH · Nov 5, 2021
- AnterionK240924 · Heidelberg Engineering GmbH · Dec 13, 2024
- AnterionK261019 · Heidelberg Engineering GmbH · Sep 11, 2026
- SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex ModuleK253837 · Heidelberg Engineering GmbH · May 7, 2026
- Unity DX (Udx)K252633 · Cylite Pty. , Ltd. · Dec 23, 2025
- Tomey Cornea/Anterior Segment OCT (CASIA2)K250553 · Tomey Corporation · Jul 18, 2025
- SPECTRALIS HRA+OCT and variantsK250868 · Heidelberg Engineering GmbH · May 12, 2025
- AnterionK240924 · Heidelberg Engineering GmbH · Dec 13, 2024
- SPECTRALIS with Flex ModuleK241163 · Heidelberg Engineering GmbH · Oct 11, 2024
- 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2); IMAGEnet6 Ophthalmic Data SystemK241081 · Topcon Corporation · Jul 17, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 31, 2023
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.1570
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files